Voraxaze (BTG International Inc.)
Welcome to the PulseAid listing for the Voraxaze drug offered from BTG International Inc.. This Carboxypeptidase [EPC],Carboxypeptidases [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | BTG International Inc. |
NON-PROPRIETARY NAME: | glucarpidase |
SUBSTANCE NAME: | GLUCARPIDASE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Carboxypeptidase [EPC],Carboxypeptidases [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, FOR SOLUTION |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2012-04-01 |
END MARKETING DATE: | 0000-00-00 |
Voraxaze HUMAN PRESCRIPTION DRUG Details:
Item Description | Voraxaze from BTG International Inc. |
LABELER NAME: | BTG International Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1000([USP’U]/1) |
START MARKETING DATE: | 2012-04-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 50633-210_2645decc-fcc7-48ab-a217-029dcd6d8ccc |
PRODUCT NDC: | 50633-210 |
APPLICATION NUMBER: | BLA125327 |
Other GLUCARPIDASE Pharmaceutical Manufacturers / Labelers: